28
Participants
Start Date
March 23, 2007
Primary Completion Date
June 24, 2021
Study Completion Date
June 24, 2021
bicalutamide
diagnostic laboratory biomarker analysis
immunohistochemistry staining method
Ralph Lauren Center for Cancer Care and Prevention, New York
Memorial Sloan Kettering Cancer Center, New York
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.
Duke Cancer Institute, Durham
Mayo Clinic Cancer Center, Rochester
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
Collaborators (1)
National Cancer Institute (NCI)
NIH
AstraZeneca
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER